MedPath

Can Multimodal Medical Strategies Can Delay Total Knee Replacement?

Not Applicable
Not yet recruiting
Conditions
Osteoarthritis, Knee
Registration Number
NCT06643845
Lead Sponsor
University Hospital, Brest
Brief Summary

Knee is the most common site of osteoarthritis. Treatment of knee osteoarthritis starts with a full course of medical therapy, followed by surgery to replace the knee with a prosthesis if this strategy fails, or in advanced cases. However, the new recommendations of the French rheumatology society, which evaluate the various treatments and position them in the treatment plan, are not well known, and the definition of a complete treatment remains unclear. The vast majority of patients are therefore referred to a surgeon after having tried a small part of the therapeutic arsenal (generally analgesics and corticosteroid or hyaluronic acid infiltrations). The goal of this study is to to select patients most likely to gain from surgery and to develop strategies that avoid the need for major surgery.

Detailed Description

Knee is the most common site of osteoarthritis. Treatment of knee osteoarthritis starts with a full course of medical therapy, followed by surgery to replace the knee with a prosthesis if this strategy fails, or in advanced cases.

However, the new recommendations of the French rheumatology society, which evaluate the various treatments and position them in the treatment plan, are not well known, and the definition of a complete treatment remains unclear. The vast majority of patients are therefore referred to a surgeon after having tried a small part of the therapeutic arsenal (generally analgesics and corticosteroid or hyaluronic acid infiltrations).

Yet medical treatment has proved effective, suggesting that it could prevent a significant number of total knee arthroplasties. In addition, osteoarthritis of the knee is associated with various co-morbidities (diabetes, cardiovascular) that medical treatment can minimize (diet, physical activity).

The effectiveness of knee prostheses has been demonstrated, but up to 20% of patients continue to experience pain, and surgical procedures induce rare but serious events. Prostheses can also be revised, and are expensive.

This research is designed for patients suffering from femoro-tibial osteoarthritis who have been proposed total knee replacement by a surgeon, and aims to develop strategies to avoid the need for major surgery until the medical treatment arsenal adapted to the patient's situation has been tried.

In the treatment of osteoarthritis, the impact of shared decision-making between rheumatologists, orthopaedic surgeons and the patient in the event of incomplete medical treatment has been shown to be important, as the decision is often modified after discussion.

The main objective of this prospective, randomized, pragmatic, non-blinded, multicenter study is to investigate whether shared decision-making coupled with multimodal medical strategies delays surgery by at least 2 years in most patients, with non-inferiority on pain and function, lower cost and fewer serious adverse events compared with total knee arthroplasty from the outset.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Age 18-90 years old
  • Femoro-tibial osteoarthritis Kellgren stage stage≥ 2 without laxity in extension;
  • A proposal of total knee replacement by a surgeon;
  • No corticosteroid joint injection within 3 months;
  • Visual analogic score pain (VAS) >40/100 but <90/100 or Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index function sub scale >40/100 at inclusion;
  • Wish to discuss medical care;
  • Able to consent and having signed a consent form.
Exclusion Criteria
  • Contraindication or no indication to surgery or medical care (severe infection for example)
  • Inflammatory arthritis
  • Lack of social insurance
  • Symptomatic (VAS pain >40) contralateral knee or hip osteoarthritis (with or without replacement)
  • Pregnant or breastfeeding woman
  • Patient under court protection, guardianship, curatorship
  • Patient deprived of liberty

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Multimodal medical care osteoarthritis is non inferior (with a threshold of 15% for pain and function) to total knee arthroplasty in symptomatic radiographic knee osteoarthritis.2 years

The outcome relates to two scales which constitute the composite principal endpoint;

* Visual Analogic Score pain, VAS (scale 0-100)

* Western Ontario and McMaster Universities function, WOMAC (scale 0-100) Success is defined by a VAS AND WOMAC scale ≤40/100 at 2 years Failure is defined by a VAS pain OR WOMAC scale \&gt; 40/100 at 2 years.

Secondary Outcome Measures
NameTimeMethod
To compare analgesic use by arm.2 years

Analgesic use by class in milligram.

Study the proportion of delayed surgery in the medical group2 years

Number of cumulated surgery (yes/no) by month in the medical group

Study the proportion of patients with severe events induced by surgery2 years

Number of severe events (Who classification) in the surgical group.

Analyze the impact of physical activity on change of body mass by arm in the randomized population.2 years

Perform analyses of body mass on whole body densitometry

To compare the 0-2 years cost using the National Health Data System between the 2 groups.0-2 years

Cost in euro between 0-2

To compare the 2-5 cost using the National Health Data System between the 2 groups.2-5 years

Cost in euro between 2-5 years

Trial Locations

Locations (21)

CHU Amiens

🇫🇷

Amiens, France

CHD Vendée

🇫🇷

La Roche-sur-Yon, France

CHU Le Mans

🇫🇷

Le Mans, France

CHU Brest

🇫🇷

Brest, France

CHU Caen

🇫🇷

Caen, France

CHU Limoges

🇫🇷

Limoges, France

GHICL- Hôpital Saint Philibert

🇫🇷

Lomme, France

CHU Montpellier

🇫🇷

Montpellier, France

CH Morlaix

🇫🇷

Morlaix, France

CHU Nantes

🇫🇷

Nantes, France

CHU Nice

🇫🇷

Nice, France

HCL

🇫🇷

Lyon, France

AP-HP Cochin

🇫🇷

Paris, France

AP-HP La pitié

🇫🇷

Paris, France

CHU Reims

🇫🇷

Reims, France

CHU Strasbourg

🇫🇷

Strasbourg, France

CHU Tours

🇫🇷

Tours, France

AP-HP Lariboisière

🇫🇷

Paris, France

AP-HP Saint-Antoine

🇫🇷

Paris, France

CHIC Quimper

🇫🇷

Quimper, France

CHU Saint Etienne

🇫🇷

Saint-Étienne, France

© Copyright 2025. All Rights Reserved by MedPath